Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic

Jurjen J. Luykx, Sisco M.P. van Veen, Arne Risselada, Paul Naarding, Joeri K. Tijdink, Christiaan H. Vinkers

Research output: Contribution to journalReview articlepeer-review

7 Downloads (Pure)

Abstract

Treatment with psychotropic medication may sometimes be jeopardised because of the COVID-19 pandemic. One underlying reason is the lack of COVID-19-specific psychopharmacology guidelines. Here, we discuss five considerations arising from our clinical experience and pharmacological background knowledge to enable safe and well-informed psychopharmacotherapy during the COVID-19 pandemic.

Original languageEnglish
Pages (from-to)471-474
Number of pages4
JournalThe British journal of psychiatry : the journal of mental science
Volume217
Issue number3
DOIs
Publication statusPublished - 1 Sept 2020

Keywords

  • COVID-19
  • epidemiology
  • prescribing
  • psychiatry
  • psychopharmacology

Fingerprint

Dive into the research topics of 'Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic'. Together they form a unique fingerprint.

Cite this